Ongoing measles transmission in the United States, driven by multiple large outbreaks and low vaccination coverage in certain communities, has produced 1,842 confirmed cases as of May 7, 2026, according to CDC surveillance data. This pace already exceeds the full-year totals from 2024 and prior years, with 93 percent of cases tied to outbreaks and most occurring in unvaccinated children and adolescents. International travel continues to seed new introductions, while seasonal factors such as summer migration and school-related mixing could accelerate spread before year-end. Weekly CDC case reports and state health department updates on outbreak containment will provide the clearest near-term signals for traders monitoring whether total 2026 incidence surpasses recent historical benchmarks.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,669,703 Объем
$7,669,703 Объем
31 дек. 2026 г.
↑2к
99%
↑3к
62%
↑4k
28%
↑5к
14%
↑7,5 тыс.
16%
↑10k
10%
↑12,5 тыс.
5%
$7,669,703 Объем
$7,669,703 Объем
31 дек. 2026 г.
↑2к
$45,436 Объем
99%
↑3к
$50,414 Объем
62%
↑4k
$170,795 Объем
28%
↑5к
$215,382 Объем
14%
↑7,5 тыс.
$174,218 Объем
16%
↑10k
$6,493,848 Объем
10%
↑12,5 тыс.
$344,846 Объем
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by multiple large outbreaks and low vaccination coverage in certain communities, has produced 1,842 confirmed cases as of May 7, 2026, according to CDC surveillance data. This pace already exceeds the full-year totals from 2024 and prior years, with 93 percent of cases tied to outbreaks and most occurring in unvaccinated children and adolescents. International travel continues to seed new introductions, while seasonal factors such as summer migration and school-related mixing could accelerate spread before year-end. Weekly CDC case reports and state health department updates on outbreak containment will provide the clearest near-term signals for traders monitoring whether total 2026 incidence surpasses recent historical benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Dec 1, 2025, 12:56 PM ET
Объем
$7,669,703Дата окончания
31 дек. 2026 г.Открытие рынка
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by multiple large outbreaks and low vaccination coverage in certain communities, has produced 1,842 confirmed cases as of May 7, 2026, according to CDC surveillance data. This pace already exceeds the full-year totals from 2024 and prior years, with 93 percent of cases tied to outbreaks and most occurring in unvaccinated children and adolescents. International travel continues to seed new introductions, while seasonal factors such as summer migration and school-related mixing could accelerate spread before year-end. Weekly CDC case reports and state health department updates on outbreak containment will provide the clearest near-term signals for traders monitoring whether total 2026 incidence surpasses recent historical benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,669,703Дата окончания
31 дек. 2026 г.Открытие рынка
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...Ongoing measles transmission in the United States, driven by multiple large outbreaks and low vaccination coverage in certain communities, has produced 1,842 confirmed cases as of May 7, 2026, according to CDC surveillance data. This pace already exceeds the full-year totals from 2024 and prior years, with 93 percent of cases tied to outbreaks and most occurring in unvaccinated children and adolescents. International travel continues to seed new introductions, while seasonal factors such as summer migration and school-related mixing could accelerate spread before year-end. Weekly CDC case reports and state health department updates on outbreak containment will provide the clearest near-term signals for traders monitoring whether total 2026 incidence surpasses recent historical benchmarks.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы